Polymorphisms of the NOS3 gene and risk of myocardial infarction in the tunisian population

Cytokine

Volumn 64, Issue 3, 2013, Pages 646-651

  Kallel, Amani ^a   Sbaï, Mohamed Hédi ^a   Sediri, Yousra ^a   Abdessalem, Salem ^a   Mourali, Mohamed Sami ^a   Feki, Moncef ^a   Mechmeche, Rachid ^a   Jemaa, Riadh ^a   Kaabachi, Naziha ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Haplotype; Myocardial infarction; NOS3 gene polymorphisms; Risk factors

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NOS3 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA;

HAPLOTYPE; MYOCARDIAL INFARCTION; NOS3 GENE POLYMORPHISMS; RISK FACTORS;

ADULT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUNISIA;

EID: 84886950678     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.09.005     Document Type: Article

References (63)

1. Lusis A.J., Fogelman A.M., Fonarow C.C. Genetic basis of atherosclerosis: part I. New genes and pathways. Circulation 2004, 110:1868-1873.
2. Kugiyama K., Yasue H., Okumura K., et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996, 94:266-272.
3. Cooke J.P., Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997, 48:489-509.
4. Hingorani A.D. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 2001, 154:521-527.
5. Marsden P., Heng H.H., Scherer S.W., et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993, 268:17478-17488.
6. Hingorani A.D., Liang C.F., Fatibene J., et al. A common variant of the endothelial nitric oxide synthase (Glu298-Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100:1515-1520.
7. Colombo M.G., Andreassi M.G., Paradossi U., et al. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 2002, 87:525-528.
8. McNamara D.M., Holubkov R., Prostava L., et al. Effect of the ASP298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 2003, 107:1598-1602.
9. Rios D.L., D'Onofrio L.O., Souza J.K., et al. Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians. Atherosclerosis 2007, 193:135-141.
10. Morray B., Goldenberg I., Moss A.J., et al. Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction. Am J Cardiol 2007, 99:1100-1105.
11. Berdili A., Sekuri C., Cam S., et al. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta 2005, 351:87-94.
12. Via M., Lopez-Alomar A., Valveny N., et al. Lack of association between Enos gene polymorphism and ischemic heart disease in the Spanish population. Am J Med Genet 2003, 116A:243-248.
13. Schmoelzer I., Renner W., Paulweber B., et al. Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and reactivity in two Austrian populations. Eur J Clin Invest 2003, 33:191-198.
14. Jaramillo P.C., Munoz M.A., Lanas M.C., Lana Z.F., Salazar L.A. Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 2006, 371:102-106.
15. Jaramillo P.C., Lanas C., Lanas F., Salazar L.A. Polymorphisms of the NOS3 gene in Southern Chilean subjects with coronary artery disease and controls. Clin Chim Acta 2010, 411:258-262.
16. Jemaa R., Kallel A., Sediri Y., et al. Association between -786TC polymorphism in the endothelial nitric oxide synthase gene and hypertension in the Tunisian population. Exp Mol Pathol 2011, 90:210-214.
17. Yoshimura M., Yasue H., Nakayama M., et al. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-C and missense Glu298Asp variants. J Invest Med 2000, 48:367-374.
18. Nakayama M., Yasue H., Yochimura M., et al. T(-786)C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 2000, 86:628-634.
19. Jo I., Moon J., Yoon S., et al. Interaction between -786TC polymorphism in the endothelial nitric oxide synthase gene and smoking for myocardial infarction in Korean population. Clin Chim Acta 2006, 365:86-92.
20. Nassar B., Rockwood K., Kirkland S.A., et al. Improved prediction of early-onset coronary artery disease using APOE, €4 BCH-K, PPAR&2 Pro12 and ENOS T-786C in polygenic model. Clin Biochem 2006, 39:109-114.
21. Wang X.L., Sim A.S., Badenhop R.F., et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996, 2:41-45.
22. Matyar S., Attila G., Acartürk E., et al. ENOS gene intron 4 a/b polymorphism is a risk factor for coronary artery disease in Southern Turky. Clin Chim Acta 2005, 354:153-158.
23. Jemaa R., Kallel A., Ben Ali S., et al. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian population. Clin Chem Lab Med 2007, 45:1476-1480.
24. Vasilakou M., Votteas V., Kasparian C., et al. Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population. Acta Cardiol 2008, 63:609-614.
25. World Health Organization. Physical status; the use and interpretation anthropometry: Report of a WHO expert committee. WHO Technical Report Series. NO; 854. Genova: WHO; 1995. p. 321-44.
26. Friedwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
27. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extraction DNA from human nucleated cells. Nucl Acids Res 1988, 16:1215.
28. Thomas G.D., Zhang W., Victor R.G. Nitric oxide deficiency as a cause of clinical hypertension; promising new drug targets for refractory hypertension. JAMA 2001, 285:2055-2057.
29. Greager M.A., Luscher T.F., Cosentino F., Beckman J.A. Diabetes and vascular disease: pathophysiology clinical consequences, and medical therapy: part I. Circulation 2003, 108:1527-1532.
30. Yoshihiro M., Yoshihiko S., Noboru K., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998, 32:3-8.
31. Galanakis E., Kofteridis D., Stratigi K., et al. Intron4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population. Hum Immunol 2008, 69:279-283.
32. Benfield A.V., Morris B.J. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hyper 2000, 13:994-998.
33. Ichihara S., Yamada Y., Fujimura T., et al. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998, 81:83-86.
34. Hooper W.C., Lally C., Austin H., et al. The relationship between polymorphism in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 1999, 116:880-886.
35. Cine N., Hatemi A.C., Erginel-Unaltuna N. Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients. Clin Genet 2002, 61:66-70.
36. Fatini C., Sofi F., Gensini E., et al. Influence of eNOS gene polymorphisms on carotid atherosclerosis. Eur J Vasc Endovasc Surg 2004, 27:540-544.
37. Hibi K., Ishigami T., Tamura K., et al. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000, 46:1626-1630.
38. Yoon Y., Song J., Hong S.H., Kim J.Q. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000, 46:1626-1630.
39. Letonja M. The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Caucasian women. Acta Cardiol 2004, 59:618-622.
40. Milutinovic A., Hruskovicova H. The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians). Folia Biol (Praha) 2005, 51:47-49.
41. Tsukada T., Yokoyama K., Arai T., et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite concentrations in humans. Biochem Biophys Res Commun 1998, 245:190-193.
42. Garg U.C., Hassid A. Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83:1774-1777.
43. Salimi S., Firoozrai M., Nourmohammadi I., Shabani M., Shafiee S.M., Mohebbi A., et al. Lack of evidence for contribution of intron4a/b polymorphism of endothelial nitric oxide synthase (NOS3) gene to plasma nitric oxide levels. Acta Cardiol 2008, 63:229-234.
44. Wang X.L., Mahaney M.C., Sim A.S., et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997, 17:3147-3153.
45. Angeline T., Isabel W., Tsongalis Gregory J. Endothelial nitric oxide gene polymorphisms nitric oxide production and coronary artery disease risk in a South Indian population. Exp Mol Pathol 2010, 89:205-208.
46. Cook J.P., Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997, 48:489-509.
47. Radomski M.W., Salas E. Nitric oxide biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis 1995, 118:S69-S80.
48. Wang J., Dudley D., Wang X.L. Haplotype-specific effects on endothelial NO synthase promotor efficiency: modifiable by cigarette smoking. Artherioscler Thromb Vasc Biol 2002, 22:e1-e4.
49. Poirier O., Mao C., Mallet C., et al. Polymorphisms of the endothelial nitric oxide synthase gene-no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 1999, 29:284-290.
50. Nassar B.A., Bevin L.D., Johnstone D.E., et al. Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease. Am Heart J 2001, 142:586-589.
51. Granath B., Taylor R.R., van Bockxmeer F.M., Mamotte C.D. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk 2001, 8:235-241.
52. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate gene. N Engl J Med 2002, 347:1916-1923.
53. Heltianu C., Costache C., Gafencu A., et al. Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction. J Cell Mol Med 2005, 9:135-142.
54. Antoniades C., Tousoulis D., Vasiliadou C., et al. Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. J Am Coll Cardiol 2005, 46:1101-1109.
55. Shimasaki Y., Yasue H., Yoshimura M., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998, 31:1506-1510.
56. Cai H., Wilcken D.E.L., Wang X.L. The Glu298_Asp (894G_T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med 1999, 77:511-514.
57. Jaramillo P.C., Lanas C., Lanas F., Salazar L.A. -786T>C Polymorphism of the endothelial nitric oxide synthase gene in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 2008, 387:105-108.
58. Paradossi U., Ciofini E., Clerico A., et al. Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu 298_Asp and T-786_C polymorphisms. Stroke 2004, 35:1305-1309.
59. Rossi G.P., Cesari M., Zanchetta M., et al. The endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 2003, 41:930-937.
60. Rios D.L.S., Callegari-Jacques S.M., Hutz M.H. Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis. Clin Chim Acta 2005, 362:138-146.
61. Tanus-Santos J.E., Desai M., Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001, 11:719-725.
62. Alvarez R., Gonzalez P., Batalla A., et al. Association between the NOS3 (-786T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 2001, 5:343-348.
63. Jia C., Liu T., Liu Z., Li M., Hu M. Joint effects of eNOS gene T-786C and ADH2 Arg47His polymorphisms on the risk of premature coronary artery disease. Thromb Res 2007, 120:679-684.